Luke Freeman-Mills
Centre for Human Genetics(GB)University of Oxford(GB)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Reproductive System and Pregnancy, Endometrial and Cervical Cancer Treatments, Cancer Genomics and Diagnostics, Immunotherapy and Immune Responses
Most-Cited Works
- → COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study(2020)1,140 cited
- → POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer(2015)310 cited
- → Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study(2016)306 cited
- → Aberrant epithelial GREM1 expression initiates colonic tumorigenesis from cells outside the stem cell niche(2014)284 cited
- → Expression of Idh1R132H in the Murine Subventricular Zone Stem Cell Niche Recapitulates Features of Early Gliomagenesis(2016)153 cited
- → Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition(2016)119 cited
- → A candidate gene study of capecitabine-related toxicity in colorectal cancer identifies new toxicity variants at DPYD and a putative role for ENOSF1 rather than TYMS(2014)101 cited
- → Five endometrial cancer risk loci identified through genome-wide association analysis(2016)95 cited
- → Nucleotide synthesis is regulated by cytoophidium formation during neurodevelopment and adaptive metabolism(2014)90 cited
- → A Polymorphic Enhancer near GREM1 Influences Bowel Cancer Risk through Differential CDX2 and TCF7L2 Binding(2014)49 cited